RDF of MGI data
pubmed
Damaris N. Lorenzo, et.al., Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency., The Journal of clinical investigation, 2015, 125
http://rdf.ncbi.nlm.nih.gov/pubmed/26168218
Damaris N. Lorenzo, et.al., Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency., The Journal of clinical investigation, 2015, 125(pubmed)
ダウンロード
SPARQL
足あと
問い合わせ
URI表示モード
Damaris N. Lorenzo, et.al., Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency., The Journal of clinical investigation, 2015, 125
pubmed
allele
http://purl.org/net/cito/citesAsAuthority
Ank2<tm3.1Bnt>
http://metadb.riken.jp/db/mgi_rdf/MGI:5646022
Ank2<tm2Bnt>
http://metadb.riken.jp/db/mgi_rdf/MGI:5763064
Ank2<tm2.1Bnt>
http://metadb.riken.jp/db/mgi_rdf/MGI:5646021
表現型アノテーション
http://purl.org/net/cito/citesAsAuthority
abnormal fat cell differentiation_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0011168STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
impaired glucose tolerance_Ank2<tm3.1Bnt>/Ank2<+>
http://metadb.riken.jp/0005293B6129CAnk2tm31BntJAnk2tm31BntAnk2Ank2Ank2tm31Bnt
insulin resistance_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0005331B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
abnormal fat cell differentiation_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0011168B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
abnormal gluconeogenesis_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0003383STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
increased circulating free fatty acid level_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0001554B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased circulating glucose level_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0005559B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
insulin resistance_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0005331STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
increased susceptibility to age related obesity_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0003212STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
increased body weight_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0001260B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased susceptibility to age related obesity_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0003212B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased circulating free fatty acid level_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0001554STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
decreased insulin secretion_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0003059B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
impaired glucose tolerance_Ank2<tm2.1Bnt>/Ank2<+>
http://metadb.riken.jp/0005293STOCKAnk2tm2BntJAnk2tm21BntAnk2Ank2tm21BntAnk2
impaired glucose tolerance_Itpr1<opt>/Itpr1<+>
http://metadb.riken.jp/0005293B6C3FeaaItpr1optJItpr1optItpr1Itpr1optItpr1
increased epididymal fat pad weight_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0009288STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
decreased insulin secretion_Itpr1<opt>/Itpr1<+>
http://metadb.riken.jp/0003059B6C3FeaaItpr1optJItpr1optItpr1Itpr1optItpr1
decreased adipocyte glucose uptake_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0030017B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased epididymal fat pad weight_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0009288B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
impaired glucose tolerance_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0005293STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
abnormal fat cell differentiation_Ank2<tm1Bnt>/Ank2<+>
http://metadb.riken.jp/0011168I129Ank2tm1BntAnk2Ank2Ank2tm1Bnt
increased susceptibility to diet-induced obesity_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0005658B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased adipocyte glucose uptake_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0030016STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
increased fat cell size_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0006094B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased circulating glucose level_Ank2<tm3.1Bnt>/Ank2<+>
http://metadb.riken.jp/0005559B6129CAnk2tm31BntJAnk2tm31BntAnk2Ank2Ank2tm31Bnt
decreased circulating insulin level_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0002727B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
impaired glucose tolerance_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0005293B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased total body fat amount_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0010024B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased susceptibility to age related obesity_Ank2<tm3.1Bnt>/Ank2<+>
http://metadb.riken.jp/0003212B6129CAnk2tm31BntJAnk2tm31BntAnk2Ank2Ank2tm31Bnt
increased muscle cell glucose uptake_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0030021B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
decreased muscle cell glucose uptake_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0030022B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
abnormal glucose homeostasis_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0002078B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
abnormal gluconeogenesis_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0003383B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
premature death_Ank2<tm2.1Bnt>/Ank2<+>
http://metadb.riken.jp/0002083STOCKAnk2tm2BntJAnk2tm21BntAnk2Ank2tm21BntAnk2
hepatic steatosis_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0002628B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased body weight_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0001260STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
premature death_Ank2<tm3.1Bnt>/Ank2<+>
http://metadb.riken.jp/0002083B6129CAnk2tm31BntJAnk2tm31BntAnk2Ank2Ank2tm31Bnt
increased circulating glucose level_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0005559STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
increased fat cell size_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0006094STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
hepatic steatosis_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0002628STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
decreased adipocyte glucose uptake_Ank2<tm1Bnt>/Ank2<+>
http://metadb.riken.jp/0030017I129Ank2tm1BntAnk2Ank2Ank2tm1Bnt
increased adipocyte glucose uptake_Ank2<tm3.1Bnt>/Ank2<tm3.1Bnt>
http://metadb.riken.jp/0030016B6129CAnk2tm31BntJAnk2tm31BntAnk2tm31BntAnk2tm31Bnt
increased susceptibility to diet-induced obesity_Ank2<tm2.1Bnt>/Ank2<tm2.1Bnt>
http://metadb.riken.jp/0005658STOCKAnk2tm2BntJAnk2tm21BntAnk2tm21BntAnk2tm21Bnt
class
http://purl.org/net/cito/citesAsAuthority
Ank2<tm3.1Bnt>
http://metadb.riken.jp/db/mgi_rdf/MGI:5646022
Ank2<tm2Bnt>
http://metadb.riken.jp/db/mgi_rdf/MGI:5763064
Ank2<tm2.1Bnt>
http://metadb.riken.jp/db/mgi_rdf/MGI:5646021
お問い合わせ
システムのお問い合わせ
画像
足跡